Arsenic sulfide enhances the therapeutic effect of hepatocellular carcinoma immunotherapy through STAT3-THBS1/CD47 pathway

被引：0
|
作者：
Kang, T. [1 ]
Feng, Z. [1 ]
Cai, Y. [1 ]
Lu, S. [1 ]
Chen, S. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Oncol, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1016/j.annonc.2024.10.248
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
228P
引用
收藏
页码：S1490 / S1491
页数：3
相关论文
共 46 条
  • [41] CD39 inhibitor (POM-1) enhances radiosensitivity of esophageal squamous cell carcinoma (ESCC) cells by promoting apoptosis through the Bax/Bcl-2/ Caspase 9/Caspase 3 pathway
    Wang, Yuchen
    Zhang, Ruijuan
    Huang, Xinran
    He, Xinyu
    Geng, Shangyi
    Guo, Wei
    Pan, Shupei
    Liu, Xiaoxiao
    Dang, Yongze
    Qu, Jingkun
    Ma, Hongbing
    Zhao, Xixi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 142
  • [42] HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8+T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma
    Shi, Xiaoqing
    Ding, Jiage
    Zheng, Yanyan
    Wang, Jiawe
    Sobhani, Navid
    Neeli, Praveen
    Wang, Gang
    Zheng, Junnian
    Chai, Dafei
    ISCIENCE, 2023, 26 (03)
  • [43] Long-term use of indomethacin leads to poor prognoses through promoting the expression of PD-1 and PD-L2 via TRIF/NF-kB pathway and JAK/STAT3 pathway to inhibit TNF-α and IFN-γ in hepatocellular carcinoma
    Xu, Pingbo
    Sun, Zhirong
    Wang, Yun
    Miao, Changhong
    EXPERIMENTAL CELL RESEARCH, 2015, 337 (01) : 53 - 60
  • [44] Novel sorafenib derivatives (SC-40, SC-43 and SC-60) show better anti-tumor effects than sorafenib in hepatocellular carcinoma through SHP-1/STAT3-mediated signaling pathway
    Tai, Wei-Tien
    Shiau, Chung-Wai
    Cheng, Ann-Lii
    Chen, Pel-Jer
    Chen, Kuen-Feng
    CANCER RESEARCH, 2012, 72
  • [45] Gemcitabine and APG-1252, a novel small molecule inhibitor of BCL-2/BCL-XL, display a synergistic antitumor effect in nasopharyngeal carcinoma through the JAK-2/STAT3/MCL-1 signaling pathway
    Fan Luo
    Fei-Teng Lu
    Miao-Zhen Qiu
    Ting Zhou
    Wen-Juan Ma
    Min Luo
    Kang-Mei Zeng
    Qiu-Yun Luo
    Wen-Tao Pan
    Lin Zhang
    Zeng-Fei Xia
    Zhong-Han Zhang
    Jia-Xin Cao
    Hong-Yun Zhao
    Li Zhang
    Da-Jun Yang
    Cell Death & Disease, 12
  • [46] Gemcitabine and APG-1252, a novel small molecule inhibitor of BCL-2/BCL-XL, display a synergistic antitumor effect in nasopharyngeal carcinoma through the JAK-2/STAT3/MCL-1 signaling pathway
    Luo, Fan
    Lu, Fei-Teng
    Qiu, Miao-Zhen
    Zhou, Ting
    Ma, Wen-Juan
    Luo, Min
    Zeng, Kang-Mei
    Luo, Qiu-Yun
    Pan, Wen-Tao
    Zhang, Lin
    Xia, Zeng-Fei
    Zhang, Zhong-Han
    Cao, Jia-Xin
    Zhao, Hong-Yun
    Zhang, Li
    Yang, Da-Jun
    CELL DEATH & DISEASE, 2021, 12 (08)
12345